As TNF induced expression of co-stimulatory molecules on OS, RMS and EwS cell lines (Figures 2, 3), we tested whether pretreatment with TNF sensitizes pediatric sarcoma cell lines towards killing by HLA-mismatched healthy donor-derived PBMCs. The gene discussed is TNF; the disease is sarcoma.